BiotechTube

somatropin + somatropin + somatropin

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Foetal Growth Problem

Conditions

Foetal Growth Problem, Small for Gestational Age

Trial Timeline

Apr 30, 2000 → Apr 30, 2003

NCT ID
NCT01734447

About somatropin + somatropin + somatropin

somatropin + somatropin + somatropin is a approved stage product being developed by Novo Nordisk for Foetal Growth Problem. The current trial status is completed. This product is registered under clinical trial identifier NCT01734447. Target conditions include Foetal Growth Problem, Small for Gestational Age.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01734447ApprovedCompleted

Competing Products

8 competing products in Foetal Growth Problem

See all competitors
ProductCompanyStageHype Score
somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskPre-clinical
22
somatropin + somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskApproved
84
somatropinNovo NordiskPhase 3
76
somatropin + somatropinNovo NordiskApproved
84
somatropin + No treatment given + No treatment givenNovo NordiskPre-clinical
22

Other Products from Novo Nordisk

Liraglutide 3.0mg + Placebo Oral Tablet + Phentermine 15 MGApproved
84
Liraglutide + SalineApproved
84
Hydrocortisone + PlaceboApproved
84
biphasic insulin aspart + insulin aspartApproved
84
Semaglutide, 1.34 mg/mL + Empagliflozin 25 MGApproved
84